[HTML][HTML] Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery

S Singh, R Kumar, S Payra, SK Singh - Cureus, 2023 - ncbi.nlm.nih.gov
Artificial intelligence (AI) has transformed pharmacological research through machine
learning, deep learning, and natural language processing. These advancements have …

A Systematic Review of Adversarial Machine Learning Attacks, Defensive Controls and Technologies

J Malik, R Muthalagu, PM Pawar - IEEE Access, 2024 - ieeexplore.ieee.org
Adversarial machine learning (AML) attacks have become a major concern for organizations
in recent years, as AI has become the industry's focal point and GenAI applications have …

[PDF][PDF] Adversarial machine learning

A Vassilev, A Oprea, A Fordyce, H Anderson - Gaithersburg, MD, 2024 - site.unibo.it
Abstract This NIST Trustworthy and Responsible AI report develops a taxonomy of concepts
and defines terminology in the field of adversarial machine learning (AML). The taxonomy is …

Privacy-enhancing technologies in biomedical data science

H Cho, D Froelicher, N Dokmai, A Nandi… - Annual review of …, 2024 - annualreviews.org
The rapidly growing scale and variety of biomedical data repositories raise important privacy
concerns. Conventional frameworks for collecting and sharing human subject data offer …

Use of generative AI in research: ethical considerations and emotional experiences

MR Farangi, H Nejadghanbar, G Hu - Ethics & Behavior, 2024 - Taylor & Francis
This study examines researchers' ethical concerns toward the deployment of GenAI in
research and their emotional responses. To acquire an in-depth understanding, we used …

Historical, philosophical and ethical roots of artificial intelligence

D Şenocak, S Koçdar, A Bozkurt - PJE, 2023 - ojs.aiou.edu.pk
Artificial intelligence (AI) generally refers to the science of creating machines that carry out
tasks inspired by human intelligence, such as speech-image recognition, learning …

[HTML][HTML] Practices and attitudes of Bavarian stakeholders regarding the secondary use of health data for research purposes during the COVID-19 pandemic: qualitative …

S McLennan, S Rachut, J Lange, A Fiske… - Journal of Medical …, 2022 - jmir.org
Background The COVID-19 pandemic is a threat to global health and requires collaborative
health research efforts across organizations and countries to address it. Although routinely …

Multi-level ethical considerations of artificial intelligence health monitoring for people living with Parkinson's disease

A Ho, I Bavli, R Mahal, MJ McKeown - AJOB Empirical Bioethics, 2024 - Taylor & Francis
Artificial intelligence (AI) has garnered tremendous attention in health care, and many hope
that AI can enhance our health system's ability to care for people with chronic and …

Unlocking the potential of big data and AI in medicine: insights from biobanking

K Akyüz, M Cano Abadía, M Goisauf… - Frontiers in …, 2024 - frontiersin.org
Big data and artificial intelligence are key elements in the medical field as they are expected
to improve accuracy and efficiency in diagnosis and treatment, particularly in identifying …

Artificial intelligent tools: evidence-mapping on the perceived positive effects on patient-care and confidentiality

NN Botha, EW Ansah, CE Segbedzi, VK Dumahasi… - BMC Digital Health, 2024 - Springer
Background Globally, healthcare systems have always contended with well-known and
seemingly intractable challenges like safety, quality, efficient and effective clinical and …